Why the study?
Does transfemoral transcatheter aortic valve implantation improve quality of life and symptoms in elderly high-risk patients with symptomatic severe aortic stenosis?
Population
62 elderly high-risk patients with symptomatic severe aortic stenosis, mean age 83 ± 5 years, 39% female.
Design
Cohort
Follow-up
9 months
Authors
Loading...
May support TAVI for QoL gains in high-risk elderly AS; leaves open randomized confirmation of durability.
Does transfemoral transcatheter aortic valve implantation improve quality of life and symptoms in elderly high-risk patients with symptomatic severe aortic stenosis?
TAVI provides rapid and sustained improvement in physical and mental health-related quality of life and symptoms in elderly high-risk patients with severe aortic stenosis.
Stortecky et al. (2012) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: